Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Nausea | 14% | x | x | |
Mental disorder | x | x | ||
Breast disorder | x | x | ||
Dizziness | x | x | ||
Dyspnoea | x | x | ||
Rash | x | x | ||
Body temperature increased | x | x | ||
Gastrointestinal disorder | x | x | ||
Headache | x | x | ||
Cardiac disorder | x | x | ||
Hyperglycaemia | x | x | ||
Hypersensitivity | x | x | ||
Hypotension | x | x | ||
Immune system disorder | x | x | ||
Nervous system disorder | x | x | ||
Multiple pregnancy | x | x | ||
Pruritus | x | x | ||
Pulmonary oedema | x | x | ||
Tachycardia | x | x | ||
Uterine haemorrhage | x | x | ||
Uterine atony | x | x | ||
Angiopathy | x | x | ||
Vomiting | x | x | ||
Injection site reaction | x | x | ||
Malnutrition | x | x | ||
Unspecified disorder of skin and subcutaneous tissue | x | x | ||
Hot flush | x | x | ||
Insomnia | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |